Rho Kinase Inhibitors [MoA] - N0000193789
Pharmacologic Class Information
| Pharmacologic Code | N0000193789 |
| Pharmacologic Name | Rho Kinase Inhibitors |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Rho Kinase Inhibitors
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Rho Kinase Inhibitors [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 70727-497 | Rhopressa | Non-Proprietary Name: Netarsudil | Solution/ Drops | Ophthalmic; Topical | Alcon Laboratories, Inc. | ACTIVE | |
| 70727-529 | Rocklatan | Non-Proprietary Name: Netarsudil And Latanoprost Ophthalmic Solution, 0.02%/0.005% | Solution/ Drops | Ophthalmic; Topical | Alcon Laboratories, Inc. | ACTIVE |